company background image
506260 logo

Anuh Pharma BSE:506260 Stock Report

Last Price

₹204.35

Market Cap

₹10.2b

7D

3.0%

1Y

19.0%

Updated

07 Feb, 2025

Data

Company Financials

Anuh Pharma Limited

BSE:506260 Stock Report

Market Cap: ₹10.2b

506260 Stock Overview

Engages in the manufacture and sale of bulk drugs and chemicals in India. More details

506260 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (17.3x) is below the Indian market (29.3x)

Earnings grew by 32.6% over the past year

Risk Analysis

High level of non-cash earnings

Dividend of 1.22% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Anuh Pharma Limited Competitors

Kopran

BSE:524280

₹8.8b

NGL Fine-Chem

BSE:524774

₹11.6b

Shree Ganesh Remedies

BSE:540737

₹10.2b

Lincoln Pharmaceuticals

BSE:531633

₹15.0b

Price History & Performance

Summary of share price highs, lows and changes for Anuh Pharma
Historical stock prices
Current Share Price₹204.35
52 Week High₹265.00
52 Week Low₹165.40
Beta0.72
1 Month Change-6.88%
3 Month Change1.36%
1 Year Change18.98%
3 Year Change92.51%
5 Year Change187.11%
Change since IPO1,066.61%

Recent News & Updates

Recent updates

Shareholder Returns

506260IN PharmaceuticalsIN Market
7D3.0%3.4%1.6%
1Y19.0%19.3%5.5%

Return vs Industry: 506260 matched the Indian Pharmaceuticals industry which returned 19.3% over the past year.

Return vs Market: 506260 exceeded the Indian Market which returned 5.5% over the past year.

Price Volatility

Is 506260's price volatile compared to industry and market?
506260 volatility
506260 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 506260 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 506260's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960175Ritesh Shahwww.anuhpharma.com

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and intermediates. The company also provides corticosteroids, such as anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines.

Anuh Pharma Limited Fundamentals Summary

How do Anuh Pharma's earnings and revenue compare to its market cap?
506260 fundamental statistics
Market cap₹10.24b
Earnings (TTM)₹590.23m
Revenue (TTM)₹6.40b

17.3x

P/E Ratio

1.6x

P/S Ratio

Is 506260 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506260 income statement (TTM)
Revenue₹6.40b
Cost of Revenue₹4.82b
Gross Profit₹1.58b
Other Expenses₹992.05m
Earnings₹590.23m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.78
Gross Margin24.73%
Net Profit Margin9.22%
Debt/Equity Ratio4.5%

How did 506260 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

21%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 19:17
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anuh Pharma Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research